AI-driven solution streamlining clinical site assessment for efficient and compliant trial launches

The client operates in Clinical Research and Life Sciences, focusing on sponsor- and CRO-oriented clinical operations. Trial timelines are delayed by poor site selection, missing documents, staffing gaps, and regulatory issues. This results in delayed FPFV, higher costs, protocol deviations, and manual coordination overhead. Traditional workflows rely on manual reviews, email questionnaires, and subjective scoring. Disconnected CRA qualification further complicates site feasibility and activation, emphasizing the need for streamlined automation.

The client faces challenges with inconsistent site scoring, limited historical performance insights, and manual document verification, leading to poor audit readiness and delays between feasibility and activation. Inefficient site feasibility evaluations result in slow, inconsistent decisions, while early operational and compliance risks often go undetected. Fragmented CRA-led site qualification processes lack digital standardization and integration into activation pipelines. There is no end-to-end traceability, with audit trails scattered across feasibility, SQV, and activation stages.

The proposed solution leverages AI agents to automate sequential clinical site evaluation tasks, ensuring validated handoffs between feasibility and pre-activation stages. Sites are assessed for suitability and operational readiness, with only qualified sites advancing to contracting and activation. This approach eliminates subjective site selection, detects risks early, digitizes CRA workflows, and generates inspection-ready audit trails. Key differentiators include protocol-driven automation, configurable AI scoring, mandatory CRA validation, and secure compliance workflows.

The approach centers on deploying specialized AI agents to automate and standardize the clinical site evaluation process. The Feasibility Agent first assesses site suitability based on protocol requirements and historical data. The Pre-Activation Agent then verifies operational readiness, ensuring all documents, staffing, and compliance checks are complete. Sequential agent workflows eliminate subjective decisions, detect risks early, and generate structured, inspection-ready audit trails.

The system workflow begins with protocol input, which feeds into the Feasibility Agent that performs scraping, scoring, questionnaire processing, and validation to shortlist suitable sites. Selected sites then move to the Pre-Activation Agent, handling CRA onboarding, SQV checklists, document validation, scheduling, and AI-driven qualification. Activation-ready sites emerge only after all steps are successfully completed, ensuring readiness and compliance. The backend leverages FastAPI, LangGraph for event-driven workflow management, PostgreSQL for data storage, Selenium for scraping, and JWT-based RBAC for secure access. The entire solution is implemented in Python 3.10+ and deployed using Docker containers for scalability and maintainability.

The solution successfully automated multi-source site evaluation, providing reliable scoring and ranking for faster decision-making. Structured CRA qualification workflows ensured consistency and efficiency across the clinical startup process. AI-generated readiness decisions minimized human error and improved site selection accuracy. End-to-end audit compliance strengthened regulatory preparedness and traceability. Overall, the platform accelerated feasibility cycles, reduced site activation failures, and enhanced operational efficiency.

The implementation highlighted the value of AI-driven automation in improving accuracy and consistency in site evaluation. Structured workflows and sequential agent handoffs reduce manual errors and ensure compliance readiness. Early detection of operational and regulatory risks prevents delays and costly site failures. Integrating CRA validation with AI insights balances automation with human oversight.